GB830832A - New quinolones and therapeutic compositions containing them - Google Patents
New quinolones and therapeutic compositions containing themInfo
- Publication number
- GB830832A GB830832A GB5201/57A GB520157A GB830832A GB 830832 A GB830832 A GB 830832A GB 5201/57 A GB5201/57 A GB 5201/57A GB 520157 A GB520157 A GB 520157A GB 830832 A GB830832 A GB 830832A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- quinolones
- nitro
- carboxy
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention comprises quinolones (excepting 1-methyl-6-nitro-4-quinolone-3-carboxylic acid and its sodium salt) of the general formula <FORM:0830832/IV (b)/1> (wherein A is a benzene ring bearing one or more substituents, e.g. phenyl, alkyl, trifluormethyl, alkoxy, hydroxy, cyano, nitro, halogen, and acyl, R is alkyl or alkenyl, which may be substituted, R1 is hydrogen or an alkyl radical, and R2 is a carboxy group or a derivative or precursor thereof, viz. salts, esters (e.g. alkyl, cyclohexyl, b -diethylaminoethyl, b -chloroethyl or phenyl esters), thiolesters, the corresponding carbinol and its ethers and esters, formyl, nitrile, and radicals of formula -COR3, where R3 is a hydrocarbon radical, optionally substituted, e.g. by an alkoxycarbonyl group); also processes for their preparation (a) by alkylating (or alkenylating) 4-hydroxy-quinolines of the general formula <FORM:0830832/IV (b)/2> (b) by esterifying quinolones in which R2 is a carboxy group or an esterifying carboxy derivative with an alcohol, thiol or phenol; (c) by acylating quinolones, containing a hydroxy group, e.g. -CH2OH in position 3; (d) by oxidizing quinolones wherein R2 is -CH2OH to the corresponding 3-formyl or 3-carboxy compounds, e.g. with potassium permanganate; (e) by reducing compounds wherein R is alkenyl to give the analogous alkyl compounds; (f) by nitrating quinolones unsubstituted in the 6-position to give the 6-nitro derivatives. 80 detailed examples are given.ALSO:Compositions for the control and treatment of bacterial infections, e.g. Salmonella dublin, comprise quinolones of the general formula <FORM:0830832/VI/1> (other than 1 - methyl - 6 - nitro - 4 - quinolone-3-carboxylic acid and its sodium salt) wherein R is alkyl or alkenyl (optionally substituted), R1 is H or alkyl, R2 is a carboxy group or a derivative or precursor thereof, A is a benzene ring which may be substituted, together with a pharmaceutical carrier or diluent, and optionally another active ingredient, e.g. aureomycin hydrochloride, the calcium salt of phenoxymethylpenicillin and 2-p-aminobenzenesulphonamino - 4 : 6 - dimethylpyrimidine. The compositions may take the form of aqueous and non-aqueous suspensions, dispersible powders, creams, ointments, tablets, pills and pessaries.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5201/57A GB830832A (en) | 1957-02-15 | 1957-02-15 | New quinolones and therapeutic compositions containing them |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5201/57A GB830832A (en) | 1957-02-15 | 1957-02-15 | New quinolones and therapeutic compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
GB830832A true GB830832A (en) | 1960-03-23 |
Family
ID=9791620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5201/57A Expired GB830832A (en) | 1957-02-15 | 1957-02-15 | New quinolones and therapeutic compositions containing them |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB830832A (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3472859A (en) * | 1966-11-01 | 1969-10-14 | Sterling Drug Inc | 1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters |
FR2085701A1 (en) * | 1970-03-13 | 1971-12-31 | Boehringer Mannheim Gmbh | |
DE2224090A1 (en) * | 1971-05-17 | 1972-11-30 | Sterling Drug Inc., New York, N.Y. (V.St.A.) | Substituted quinoline carboxylic acids and esters and processes for their preparation |
FR2228488A1 (en) * | 1973-05-11 | 1974-12-06 | Ciba Geigy Ag | |
US4146625A (en) | 1976-07-16 | 1979-03-27 | E. I. Du Pont De Nemours And Company | Quinolonecarboxylic acids for control of bacterial diseases in plants |
EP0028698A1 (en) * | 1979-10-05 | 1981-05-20 | Tanabe Seiyaku Co., Ltd. | Quinoline compounds, process for their preparation, and pharmaceutical compositions |
EP0062001A2 (en) * | 1981-03-24 | 1982-10-06 | Ciba-Geigy Ag | Acyl quinolinone derivatives, processes for their preparation, pharmaceutical compositions containing them and their use |
US4390541A (en) | 1980-12-19 | 1983-06-28 | Lilly Industries Limited | Quinolone derivatives and their use in a method of controlling an immediate hypersensitivity disease |
US4544747A (en) * | 1979-02-26 | 1985-10-01 | Otsuka Pharmaceutical Company, Limited | Quinoline carboxylic acid derivatives |
EP0179239A2 (en) * | 1984-09-17 | 1986-04-30 | Sterling Drug Inc. | 7-(Pyridinyl)-/-alkyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid having antibacterial activity and preparation thereof |
US4780468A (en) * | 1987-08-07 | 1988-10-25 | Warner-Lambert Company | 8-trifluoromethyl quinolones as antibacterial agents |
US4782156A (en) * | 1984-07-18 | 1988-11-01 | Bayer Aktiengesellschaft | Nitriles of halogenated quinolonecarboxylic acids |
-
1957
- 1957-02-15 GB GB5201/57A patent/GB830832A/en not_active Expired
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3472859A (en) * | 1966-11-01 | 1969-10-14 | Sterling Drug Inc | 1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters |
FR2085701A1 (en) * | 1970-03-13 | 1971-12-31 | Boehringer Mannheim Gmbh | |
DE2224090A1 (en) * | 1971-05-17 | 1972-11-30 | Sterling Drug Inc., New York, N.Y. (V.St.A.) | Substituted quinoline carboxylic acids and esters and processes for their preparation |
FR2228488A1 (en) * | 1973-05-11 | 1974-12-06 | Ciba Geigy Ag | |
US3960868A (en) * | 1973-05-11 | 1976-06-01 | Ciba-Geigy Corporation | Derivatives of 6,7 or 8 cycloalkyl 4-oxo quinoline 3 carboxylic acid |
US4146625A (en) | 1976-07-16 | 1979-03-27 | E. I. Du Pont De Nemours And Company | Quinolonecarboxylic acids for control of bacterial diseases in plants |
US4544747A (en) * | 1979-02-26 | 1985-10-01 | Otsuka Pharmaceutical Company, Limited | Quinoline carboxylic acid derivatives |
EP0028698A1 (en) * | 1979-10-05 | 1981-05-20 | Tanabe Seiyaku Co., Ltd. | Quinoline compounds, process for their preparation, and pharmaceutical compositions |
US4327101A (en) | 1979-10-05 | 1982-04-27 | Tanabe Seikaku Co., Ltd. | Quinoline compound useful as antibacterial agents in warm-blooded animals |
US4390541A (en) | 1980-12-19 | 1983-06-28 | Lilly Industries Limited | Quinolone derivatives and their use in a method of controlling an immediate hypersensitivity disease |
EP0062001A2 (en) * | 1981-03-24 | 1982-10-06 | Ciba-Geigy Ag | Acyl quinolinone derivatives, processes for their preparation, pharmaceutical compositions containing them and their use |
US4476132A (en) * | 1981-03-24 | 1984-10-09 | Ciba-Geigy Corporation | Acylquinolinone derivatives, and antiallergic preparations and methods of inhibiting allergic reactions using them |
EP0062001B1 (en) * | 1981-03-24 | 1987-05-27 | Ciba-Geigy Ag | Acyl quinolinone derivatives, processes for their preparation, pharmaceutical compositions containing them and their use |
US4782156A (en) * | 1984-07-18 | 1988-11-01 | Bayer Aktiengesellschaft | Nitriles of halogenated quinolonecarboxylic acids |
EP0179239A2 (en) * | 1984-09-17 | 1986-04-30 | Sterling Drug Inc. | 7-(Pyridinyl)-/-alkyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid having antibacterial activity and preparation thereof |
EP0179239A3 (en) * | 1984-09-17 | 1986-08-13 | Sterling Drug Inc. | 7-(pyridinyl)-/-alkyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid having antibacterial activity and preparation thereof |
US4780468A (en) * | 1987-08-07 | 1988-10-25 | Warner-Lambert Company | 8-trifluoromethyl quinolones as antibacterial agents |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB830832A (en) | New quinolones and therapeutic compositions containing them | |
GB808105A (en) | New pharmaceutical compositions | |
GB1147336A (en) | Quinoline-3-carboxylic acid derivatives | |
ES8201167A1 (en) | Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor. | |
GB910255A (en) | Benzodiazepine derivatives and a process for the manufacture of same | |
GB913710A (en) | 2,4-diaminopyrido(2,3-d) pyrimidines and the manufacture thereof | |
DE2965701D1 (en) | 1-imidazol-2-ylidene-3-thienyl-urea derivatives, processes therefor, and pharmaceutical compositions | |
GB1066347A (en) | New derivatives of 7-amino-cephalosporamic acid and process for their manufacture | |
GB858792A (en) | New pyridazine derivatives and processes for their manufacture | |
GB951026A (en) | The manufacture of sulphonamides | |
GB1105007A (en) | Nitrone derivatives and processes for preparation thereof | |
GB1093113A (en) | 6-substituted penicillanyl alcohols | |
GB1031082A (en) | Benzene derivatives | |
GB1055741A (en) | Pharmaceutical compositions comprising substituted urea derivatives | |
GB1088880A (en) | ª‡-cycloalkyleneimino-substituted esters | |
GB1077177A (en) | New benzthiazole compounds and their application | |
GB1122194A (en) | Thioureas and their manufacture and use | |
GB855022A (en) | Improvements in and relating to carbostyril derivatives | |
GB920753A (en) | Process for the preparation of di-benzoxazolyl-ethylene compounds | |
FR1604803A (en) | Vitamin b deriv | |
GB861527A (en) | New salts of penicillins | |
GB912973A (en) | Phenthiazine derivatives | |
GB1049769A (en) | Organic compounds containing an isocyclic and a heterocyclic non-aromatic ring and aprocess for the production of these compounds | |
GB884883A (en) | Diamino-5,8-quinoline-quinone derivatives | |
GB1065965A (en) | Dibenzocyclooctenes |